AdaptHealth (NASDAQ: AHCO) to redeem $325M 6.125% 2028 notes
AdaptHealth Corp. announced that its subsidiary, AdaptHealth LLC, plans to redeem all $325 million of its outstanding 6.125% Senior Notes due 2028. The redemption is conditional upon securing sufficient net proceeds from a borrowing under an existing delayed draw term loan facility. The redemption is expected to occur on August 1, 2026, with payment on August 3, 2026, after which interest will cease to accrue on the notes.
AdaptHealth to redeem $325M of 6.125% Senior Notes due 2028, redemption expected Aug. 1
AdaptHealth (AHCO) has announced its intention to redeem all $325 million of its 6.125% Senior Notes due 2028. The redemption is contingent on securing sufficient financing from a delayed draw term loan. The redemption date is expected to be August 1, 2026, with payment by August 3, 2026.
AdaptHealth discloses patient data was stolen in cyberattack
AdaptHealth recently disclosed that a cyberattack resulted in the theft of patient data, including personally identifiable information and protected health information. The incident, which involved a social engineering attack on a third-party contractor's user session, allowed unauthorized access to cloud-based business applications and external EHR portals. While the full scope and volume of stolen data are still under investigation, AdaptHealth confirmed that Social Security numbers and financial account information were not stored in the affected systems and that the incident has not materially impacted operations.
AdaptHealth Data Breach Lawsuit Investigation
Shamis & Gentile P.A., a class action law firm, is investigating a data breach at AdaptHealth Corp. that exposed sensitive consumer information, including insurance billing passwords, personally identifiable information, and protected health information. The breach was disclosed on June 27, 2026, and affected individuals may be entitled to compensation. AdaptHealth, founded in 2012, provides home healthcare equipment and services.
Adapthealth CCO Russell Schuster sells $117,711 in company stock
AdaptHealth Corp. CCO Russell E. Schuster III sold 11,275 shares of company stock for a total of $117,711. The sale was executed via a Rule 10b5-1 trading plan. Despite recent negative earnings, analysts predict profitability for AdaptHealth this year, with Truist Securities maintaining a "Buy" rating.
AdaptHealth Data Breach Compromises Patient Personal and Health Info
AdaptHealth Corp., a prominent provider of home healthcare equipment, has reported a data breach to the U.S. Securities and Exchange Commission on June 27, 2026. The incident potentially exposed patient passwords for insurance billing, personally identifiable information (PII), and protected health information (PHI). While the specific details of the breach, including the number of affected individuals and the method of compromise, remain undisclosed, individuals are advised to watch for direct communication from AdaptHealth for further instructions and protective services.
AdaptHealth Data Breach Puts Patient Info at Risk, Lawsuit Possible
AdaptHealth has disclosed a data breach affecting personally identifiable information, protected health information, and insurance billing account passwords. This incident, caused by a social engineering attack on a third-party contractor's account, may lead to a class action lawsuit. Attorneys are seeking individuals impacted by the breach to investigate potential claims for compensation and to ensure AdaptHealth implements stronger data protection measures.
AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems
AdaptHealth Corp. (NASDAQ: AHCO) is investigating a cybersecurity incident that led to unauthorized access to its cloud-based business applications, including patient management systems, and the exfiltration of data. The company confirmed that a social engineering attack on a third-party contractor's user session exposed insurance billing passwords and patient identifiable/protected health information, though Social Security numbers and financial account details were not compromised. AdaptHealth has contained the incident and is continuing its investigation into the full scope and financial impact.
Behavioral Patterns of AHCO and Institutional Flows
The article analyzes Adapthealth Corp. (NASDAQ: AHCO) based on AI models, indicating a strong overweight bias across all time horizons due to an oscillating pattern. It outlines three distinct trading strategies: a Long Position, a Momentum Breakout, and a Short Risk Hedging strategy, each with specific entry zones, targets, and stop losses. The analysis also provides multi-timeframe signal strength, support, and resistance levels.
Should AdaptHealth’s Third-Party Cybersecurity Breach Shift How AHCO Investors View Tech Risk Management?
AdaptHealth Corp. experienced a cybersecurity breach involving a third-party contractor, exposing patient and internal systems data but not Social Security numbers or financial accounts. While the stock's reaction has been muted, the incident highlights increased operational and regulatory risks. Investors should consider how this data breach shapes AdaptHealth's investment narrative, particularly concerning operational resilience and technology risk management.
AdaptHealth (AHCO) Stock Forum and Discussion
This article provides a discussion forum for AdaptHealth (AHCO) stock. It serves as a platform for investors and interested parties to share opinions and insights regarding the company's performance and future outlook. The content is primarily user-generated discussion.
AdaptHealth Update
Faruqi & Faruqi, LLP is investigating potential claims against AdaptHealth Corp. (NASDAQ: AHCO) following allegations that the company misrepresented its organic growth trajectory and materially overstated its financial prospects. The lawsuit highlights a report from Jehoshaphat Research claiming AdaptHealth manipulated past organic growth numbers without disclosure, leading to a significant drop in its stock price on July 19, 2021. Investors who suffered losses exceeding $50,000 are encouraged to contact the firm by the September 27, 2021 deadline to discuss lead plaintiff options.
AdaptHealth Reports Material Cybersecurity Incident and Theft of Patient Data
AdaptHealth, a publicly traded healthcare company, has reported a material cybersecurity incident to the SEC involving unauthorized access and exfiltration of patient data. The breach originated from a social engineering attack on a third-party contractor, leading to the compromise of internal patient management and document storage systems. While the investigation is ongoing and the full extent of the data theft is unknown, the incident is considered material due to the potential volume of at-risk data, and the ShinyHunters threat group has reportedly claimed responsibility, threatening to leak the data if ransom is not paid.
AdaptHealth investigating data breach; shares down 7%
AdaptHealth (ADPT) announced that some of its computer systems were affected by a cybersecurity attack in mid-June. The company stated that the potential theft of data is "material" due to its nature and volume. Following this news, AdaptHealth's shares were down 7%.
Form 144 AdaptHealth Corp. For: 1 July By Investing.com
This article from Investing.com is a Form 144 filing for AdaptHealth Corp., dated July 1. It emphasizes the risks associated with trading financial instruments and cryptocurrencies, advising investors to be fully informed and seek professional advice. The content also notes that data provided may not be real-time or accurate and is for indicative purposes only.
Form 144 AdaptHealth Corp. For: 1 July By Investing.com
This article from Investing.com announces the filing of Form 144 for AdaptHealth Corp. on July 1st. Form 144 is a notice of the intent to sell restricted securities. The brief notice provides a direct update regarding this financial filing.
AdaptHealth Corp. Financial Disclosures & SEC Filings
This page provides access to AdaptHealth Corp.'s financial disclosures and SEC filings, including Forms 10-K, 10-Q, and 8-K, allowing users to evaluate the company's financial performance. It lists a chronological overview of earnings reports, corporate events, and conference transcripts from 2023 to 2026, highlighting key business updates and strategic developments for AHCO.
Form 4 Adapthealth Corp For: 26 June By Investing.com
This article from Investing.com is a placeholder announcement for a Form 4 filing by Adapthealth Corp on June 26th. It provides no significant details about the filing itself but is surrounded by extensive financial market data, news headlines, and promotional content common to financial news platforms. The core content is simply the notification of the Form 4.
Enterprise value to EBIT forward of AdaptHealth Corp. – NASDAQ:AHCO
This article provides a brief financial update on AdaptHealth Corp. (NASDAQ: AHCO), specifically focusing on its enterprise value to EBIT forward metric. The information is presented within the context of TradingView's platform, indicating that detailed financial data for the company is available there.
AdaptHealth Corp. Actuals & Estimates (NASDAQ:AHCO)
This article provides an overview of AdaptHealth Corp. (NASDAQ: AHCO) stock, including its current price, market capitalization, and historical performance. It details analyst forecasts, financial actuals and estimates, revenue, and earnings reports, confirming the next earnings date is August 11, 2026. The information is presented to help investors understand the company's financial health and stock outlook.
AdaptHealth (AHCO) director Gregory Belinfanti receives 18,999 restricted stock units
AdaptHealth Corp. director Gregory Belinfanti was granted 18,999 restricted stock units (RSUs) at no purchase price, increasing his direct holdings to 104,269 shares. This transaction, categorized as a grant/award, was reported in a Form 4 filing and indicates an increase in his equity position, with the RSUs settling in common stock upon vesting. The filing does not indicate any stock sales by Belinfanti.
AdaptHealth (AHCO) director receives 18,999 restricted stock units, holds 64,044 shares
AdaptHealth Corp. director David Solomon Williams III was granted 18,999 restricted stock units (RSUs) on June 24, 2026, as part of his equity-based compensation. These RSUs were valued at $0.00 per share and will convert to common stock upon vesting. Following this grant, Williams holds a total of 64,044 shares of AdaptHealth common stock, reflecting a compensation-related acquisition rather than an open-market transaction.
AdaptHealth (AHCO) director awarded 18,999 restricted stock units in Form 4 filing
AdaptHealth (AHCO) director Bradley J. Coppens was granted 18,999 restricted stock units (RSUs) of Common Stock, as reported in a Form 4 filing. These RSUs will be settled in common stock upon vesting and were awarded as compensation with a price of $0.00 per share. Following this transaction, Coppens directly holds a total of 96,345 shares of AdaptHealth.
AdaptHealth (AHCO) director Kenneth Samet submits initial Form 3 ownership report
AdaptHealth (AHCO) director Kenneth A. Samet has filed an initial Form 3, which is a statement of beneficial ownership for insiders. The filing indicates his role as a director but reports no stock transactions or derivative positions at this time. This Form 3 establishes a baseline of his current beneficial ownership, providing transparency without immediate implications of stock changes.
AdaptHealth (AHCO) director Terence Connors granted 18,999 restricted stock units
AdaptHealth director Terence J. Connors was granted 18,999 restricted stock units (RSUs) on June 24, 2026, which will be settled in common stock upon vesting. This transaction, reported via a Form 4 filing, increases his direct holding to 95,262 shares of AdaptHealth Common Stock. The RSUs were awarded as compensation rather than purchased, aligning his equity with the company's success.
AdaptHealth (AHCO) director Susan T. Weaver awarded 18,999 restricted stock units
AdaptHealth Corp. director Susan T. Weaver was granted 18,999 restricted stock units (RSUs) of common stock at a price of $0.00 per share, as reported in a recent Form 4 filing. This award increases her direct holdings to 40,345 shares, with an additional 73,472 shares held indirectly through an Irrevocable Trust. The RSUs will convert to common stock upon vesting and were awarded as compensation rather than an open-market transaction.
Price to sales forward of AdaptHealth Corp. – NASDAQ:AHCO
This article displays the "Price to sales forward" metric for AdaptHealth Corp. (NASDAQ: AHCO) on the TradingView platform. It presents financial data for the company within the health services sector. The content itself seems to be a snapshot of a financial data point rather than an analytical piece.
How Truist’s Support and Governance Votes At AdaptHealth (AHCO) Have Changed Its Investment Story
Truist Securities reiterated its positive stance on AdaptHealth (AHCO) after recent meetings with management, reinforcing confidence in its governance and leadership following the 2026 annual stockholder meeting. While boosting sentiment, this commentary doesn't fundamentally alter the core investment narrative, which still focuses on achieving revenue guidance, improving margins, and successful acquisition integration. Investors should monitor ongoing losses, execution risks in acquisitions, and the use of the new credit facility.
Price to earnings forward of AdaptHealth Corp. – BOATS:AHCO
This article provides the "Price to earnings forward" financial data for AdaptHealth Corp. (AHCO) under the BOATS (Blue Ocean Alternative Trade System) listing on TradingView. It indicates that the market is currently closed, and no trades have occurred for this metric. The page includes various navigation and information sections typical of a financial data platform.
How Truist’s Support and Governance Votes At AdaptHealth (AHCO) Have Changed Its Investment Story
Truist Securities reiterated its positive stance on AdaptHealth (AHCO) after meetings with management, and the company's annual stockholder meeting approved key governance items, boosting confidence in its leadership. While these developments reinforce the investment narrative regarding management and governance, they do not fundamentally alter the near-term catalysts or risks for investors. AdaptHealth still faces challenges such as ongoing losses, execution risks with acquisitions, and the efficient use of its new credit facility, which remain central concerns for investors.
Enterprise value to revenue forward of AdaptHealth Corp. – NASDAQ:AHCO
This article provides a brief financial overview for AdaptHealth Corp. (NASDAQ: AHCO) focusing on its enterprise value to revenue forward. It appears to be a stub or a placeholder from TradingView, indicating financial data without presenting specific figures. The content is primarily navigational and copyright information from the platform.
AdaptHealth (AHCO) Stock Trades Up, Here Is Why
Shares of AdaptHealth (AHCO) rose 2.5% after a Truist Securities analyst reiterated a Buy rating and a $14 price target, expressing confidence in the company after management meetings. This positive outlook appears to have boosted investor sentiment despite a significant loss reported in the fourth quarter of 2025. The stock is up 3% year-to-date but remains well below its 52-week high, and long-term investors since 2021 would have seen a substantial decline in value.
Enterprise value to revenue forward of AdaptHealth Corp. – BOATS:AHCO
This article focuses on the "Enterprise value to revenue forward" metric for AdaptHealth Corp. (AHCO). It indicates that the company's financial data and specifics regarding this metric can be found within the TradingView platform under the BOATS:AHCO ticker. The article itself does not provide the specific value or analysis of this metric but serves as a header or link to such information.
(AHCO) Movement Within Algorithmic Entry Frameworks
The article analyzes Adapthealth Corp. (NASDAQ: AHCO) using AI models, highlighting weak near-term sentiment but strong long-term potential. It details an exceptional risk-reward setup targeting a 12.5% gain, alongside three distinct trading strategies (Position Trading, Momentum Breakout, and Risk Hedging) tailored to different risk profiles. The analysis also includes multi-timeframe signal analysis with support and resistance levels.
AdaptHealth (AHCO) Stock Trades Up, Here Is Why
Shares of AdaptHealth Corp. (AHCO) increased by 2.5% after a Truist Securities analyst reiterated a Buy rating and a $14 price target, boosting investor confidence. This positive movement follows an earlier period of volatility, including a significant drop four months prior due to a substantial GAAP loss despite a revenue beat. The stock is up 3% year-to-date, but still significantly below its 52-week high, indicating a challenging long-term performance for early investors.
AdaptHealth stock maintains buy rating at Truist on contract progress
Truist Securities has reiterated its Buy rating and $14.00 price target for AdaptHealth (NASDAQ:AHCO), citing solid core trends and progress on a recent capitated contract. The firm sees further contract wins and efficiency benefits from technology investments. AdaptHealth's stock is considered undervalued, with analysts predicting profitability this year.
AdaptHealth shareholders elect directors and approve proposals at annual meeting
AdaptHealth Corp. shareholders approved all proposals at their annual meeting, including the election of nine directors for one-year terms. They also ratified KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, and approved the compensation of named executive officers. These decisions follow AdaptHealth's recent first-quarter 2026 earnings report, which indicated a revenue beat but an EPS miss.
AdaptHealth shareholders elect directors and approve proposals at annual meeting
AdaptHealth Corp. shareholders have approved all proposals at their recent annual meeting, including the election of nine directors and the ratification of KPMG LLP as their independent registered public accounting firm for the fiscal year ending December 31, 2026. They also approved a non-binding advisory vote on executive officer compensation. These decisions follow AdaptHealth's Q1 2026 earnings report, which showed missed EPS but exceeded revenue expectations, impacting investor sentiment.
Form 8K Adapthealth Corp For: 22 June By Investing.com
This article from Investing.com is a straightforward announcement regarding an 8K filing by Adapthealth Corp for June 22. It provides the title of the filing and specifies the company and date without offering further details or analysis. The main purpose of the article appears to be reporting the existence of this SEC filing.
Form 8K Adapthealth Corp For: 22 June By Investing.com
This article reports that Adapthealth Corp filed a Form 8K on June 22. It briefly mentions recent market performance for various indices, commodities, bonds, and stocks, and highlights trending stocks and investment challenges. The main focus is the SEC filing by Adapthealth Corp.
AdaptHealth (NASDAQ: AHCO) reports 2026 annual meeting director, auditor and pay votes
AdaptHealth Corp. (NASDAQ: AHCO) announced the results of its 2026 annual stockholders meeting. Shareholders elected nine directors, ratified KPMG LLP as the independent registered public accounting firm for fiscal year 2026, and approved the compensation for named executive officers on a non-binding advisory basis. The meeting had a significant quorum with 88.67% of voting power represented.
Adapthealth Corp (AHCO) Earnings Forecast: Future EPS & Revenue Growth Estimates
Adapthealth Corp (AHCO) currently has an earnings forecast score of 8.00, placing it 66th in the Healthcare Equipment & Supplies industry. Analysts have an average price target of $13.00 for AHCO, with a majority recommending a "Buy" based on ratings from 8 analysts. The company's expected revenue for the next quarter is $848.58M, and EPS is forecasted at $0.18 for the upcoming quarter.
How (AHCO) Movements Inform Risk Allocation Models
This article analyzes Adapthealth Corp. (NASDAQ: AHCO) stock movements, indicating positive near-term sentiment while noting a weak mid-term bias within a long-term strong context. It highlights an exceptional 39.7:1 risk-reward setup, targeting an 11.9% gain against a 0.3% risk, and provides three distinct AI-generated trading strategies (Position, Momentum Breakout, and Risk Hedging) tailored for different risk profiles.
3 Reasons to Avoid AHCO and 1 Stock to Buy Instead
AdaptHealth (AHCO) has underperformed for months, showing a small loss compared to the S&P 500's significant gain. StockStory recommends avoiding the stock due to flatlining revenue growth, declining EPS, and ineffective past growth initiatives with a low return on invested capital. Instead, they suggest investing in a dominant software business and highlight "Strong Momentum" stocks, noting past successes like Nvidia and Comfort Systems.
New COO Appointment and Pay Bump Could Be A Game Changer For AdaptHealth’s (AHCO) Capitated Push
AdaptHealth Corp. appointed Daniel McFadden as COO, increasing his salary, as the company focuses on a new five-year, over US$1 billion capitated contract expected to add US$200 million in annual recurring revenue. This move signals the board's emphasis on operational execution to translate the significant revenue into consistent profitability, though risks remain regarding execution missteps and profit volatility. Investors are watching how the new leadership will manage the contract's ramp-up and integrate acquisitions to improve the company's financial health.
AdaptHealth (AHCO) reports earnings tomorrow: What to expect
This article states that AdaptHealth (AHCO) is scheduled to report its earnings tomorrow. Investors and analysts will be keen to see the company's financial performance and outlook. The report will likely detail revenue, earnings per share, and other key financial metrics.
AHCO Technical Analysis & Stock Price Forecast
The article provides a technical analysis for Adapthealth Corp (AHCO), concluding with an overall "Strong Sell" consensus based on various indicators. It details the stock's performance against moving averages, its RSI and MACD status, and identifies key support and resistance levels. The analysis indicates that AHCO is currently trading below its 200-day moving average, suggesting a bearish long-term trend.
AdaptHealth (AHCO) reports earnings tomorrow: What to expect
This article indicates that AdaptHealth (AHCO) is scheduled to report its earnings tomorrow. It suggests that investors should be aware of the upcoming financial release. The content implies an anticipation of what the earnings report might reveal.
A Look At AdaptHealth (AHCO) Valuation As Shares Face Mixed Short And Long Term Returns
AdaptHealth (AHCO) is currently trading at $9.73, which is below its narrative fair value of $11.00 and indicates it may be undervalued. The company benefits from increased demand for home healthcare due to an aging population and a new multi-year contract worth over $1 billion. However, significant infrastructure investments for this contract are expected to increase operating expenses and capital expenditures, potentially impacting free cash flow and net margins until 2026.
Insider Sell: Schuster III Russell E. Sells Shares of AdaptHealt
Schuster III Russell E., Chief Commercial Officer of AdaptHealth Corp (AHCO), sold 11,275 shares of the company on June 1, 2026. Following this transaction, he now holds 136,538 shares. AdaptHealth Corp is a home healthcare equipment and medical supplies provider, and the stock was trading at $10.06, considered fairly valued against its GF Value of $10.57.
